ARCH Venture Partners XII, LLC — SEC insider filings

SEC reporting owner CIK 1979548. 17 insider filings on record with FilingPulse; latest filed 2026-10-19.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2023-09-20 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Metsera, Inc. (MTSR)Director, 10% owner22 legs · 2,222,222 sh · $39,999,996—9
Neumora Therapeutics, Inc. (NMRA)10% owner920 legs · 3,922,764 sh · $36,430,001—12
Prime Medicine, Inc. (PRME)10% owner22 legs · 6,230,300 sh · $29,999,990——
Seaport Therapeutics, Inc. (SPTX)10% owner11 leg · 1,100,000 sh · $19,800,000—4
CITY THERAPEUTICS, INC. (CTY)10% owner21 leg · 170,000 sh · $3,060,000—6
Rapport Therapeutics, Inc. (RAPP)10% owner1——3

Insider filings — ARCH Venture Partners XII, LLC

FiledFormIssuerReported transactionsSource
2026-10-194CITY THERAPEUTICS, INC. (CTY)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, Burow Kristina, GILLIS STEVEN
Conversion (C): 3,294,900 · Conversion (C): 5,482,309 · Conversion (C): 2,027,006 · Purchase (P): 170,000 @ $18 · Conversion (C): 3,000,000 (derivative) @ $0 · Conversion (C): 4,991,633 (derivative) @ $0 · +1 moreEDGAR
2026-10-153CITY THERAPEUTICS, INC. (CTY)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, Burow Kristina, GILLIS STEVEN
Holdings only — no transactions reportedEDGAR
2026-05-044Seaport Therapeutics, Inc. (SPTX)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina, GILLIS STEVEN
Conversion (C): 2,513,686 · Conversion (C): 2,681,265 · Purchase (P): 1,100,000 @ $18 · Conversion (C): 2,513,686 (derivative) @ $0 · Conversion (C): 2,681,265 (derivative) @ $0EDGAR
2025-11-144Metsera, Inc. (MTSR)
jointly with ARCH Venture Fund XII, L.P., ARCH Venture Partners XII, L.P., ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Disposition to issuer (D): 18,503,128 · Disposition to issuer (D): 8,313,680EDGAR
2025-10-294Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT, BYBEE CLINTON
Purchase (P): 1,915,700 @ $2.61EDGAR
2025-08-014Prime Medicine, Inc. (PRME)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P.
Purchase (P): 3,030,300 @ $3.30EDGAR
2025-02-034Metsera, Inc. (MTSR)
jointly with ARCH Venture Fund XII, L.P., ARCH Venture Partners XII, L.P., ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Conversion (C): 16,006,949 · Conversion (C): 7,523,682 · Purchase (P): 1,432,224 @ $18 · Purchase (P): 789,998 @ $18 · Conversion (C): 19,933,333 (derivative) · Conversion (C): 15,000,000 (derivative) · +3 moreEDGAR
2024-06-104Rapport Therapeutics, Inc. (RAPP)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina, GILLIS STEVEN
Conversion (C): 3,728,738 @ $0 · Conversion (C): 20,000,000 (derivative) @ $0 · Conversion (C): 11,924,138 (derivative) @ $0EDGAR
2024-02-204Prime Medicine, Inc. (PRME)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P.
Purchase (P): 3,200,000 @ $6.25EDGAR
2023-12-124Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT, BYBEE CLINTON
Other (J): 703,061 · Other (J): 1,176,593EDGAR
2023-11-154Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 31,653 @ $11.75 · Purchase (P): 3,357 @ $11.98EDGAR
2023-11-134Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 69,127 @ $10.78 · Purchase (P): 23,124 @ $11.79 · Purchase (P): 31,079 @ $10.53 · Purchase (P): 11,844 @ $11.37 · Purchase (P): 5,431 @ $11.75EDGAR
2023-11-074Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 22,420 @ $11.38 · Purchase (P): 43,082 @ $11.55 · Purchase (P): 30,192 @ $11.50EDGAR
2023-09-294Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 16,841 @ $13.06 · Purchase (P): 25,110 @ $13.69 · Purchase (P): 34,560 @ $13.98EDGAR
2023-09-274Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 34,000 @ $11.73 · Purchase (P): 24,504 @ $12.31EDGAR
2023-09-254Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 40,000 @ $11.14 · Purchase (P): 30,773 @ $10.80 · Purchase (P): 29,967 @ $11.65EDGAR
2023-09-204Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT, BYBEE CLINTON
Conversion (C): 684,167 · Conversion (C): 1,144,973 · Conversion (C): 6,895,021 · Conversion (C): 6,576,400 · Conversion (C): 2,124,143 · Purchase (P): 1,500,000 @ $17 · +5 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2022-04-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1979548 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs